Commentary on: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase III, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines
Aesthetic surgery journal